Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide dosing follows a gradual titration protocol designed to help your body adjust while reducing nausea and gastrointestinal side effects. Most patients begin at 0.25 mg weekly and progress based on individual tolerance and clinical response. PlexusDx compounds pharmaceutical-grade semaglutide through licensed 503A pharmacies, allowing flexible dosing personalization without membership fees or insurance barriers.
How Semaglutide Dose Titration Works
Semaglutide treatment uses a step-wise dosing schedule that prevents your system from being overwhelmed by sudden changes. During week one through four, you typically receive 0.25 mg injected subcutaneously once weekly. This introductory phase allows your GLP-1 receptors to begin responding while your digestive system acclimates to appetite suppression. Most patients tolerate this opening dose well, though some experience mild nausea that resolves within days.
The second month introduces a 0.5 mg weekly dose, maintaining the same injection frequency but increasing receptor activation. At week five through eight, your body has adapted to the initial hormonal signaling, making the higher dose more comfortable. Clinical observation shows that patients often report improved appetite control and early weight reduction during this phase. The gradual progression reduces the likelihood of severe side effects that can occur with rapid dose escalation.
Progressive Dose Increases and Maintenance Levels
After your body stabilizes at 0.5 mg, the protocol advances to 1.0 mg weekly during months three and four. This mid-range dose produces meaningful metabolic changes, including reduced food cravings and extended satiety between meals. Many patients achieve their target weight loss velocity at this dosage without requiring further increases. Maintaining this level for 8-12 weeks allows your clinician to assess whether additional titration is necessary based on your individual response.
The final therapeutic steps involve progressing to 1.7 mg or 2.4 mg weekly, depending on your weight loss goals and tolerance profile. Doses above 1.0 mg typically occur at four-week intervals to ensure your system adapts smoothly. Once you reach your target maintenance dose, you continue that amount weekly for the duration of your treatment program. PlexusDx personalizes this entire sequence based on your medical history, baseline weight, and metabolic markers—your dose may increase, but your price stays flat at $149 per month.
Why Personalization Matters in Your Dosing Plan
Not every patient requires the same final dose to achieve meaningful results, which is why one-size-fits-all protocols often underperform. Your genetics influence how efficiently your GLP-1 receptors respond to semaglutide, how your pancreas regulates insulin, and how your appetite-control pathways function. The PlexusDx Precision Peptide Genetic Test examines 49 peptides across 14 metabolic pathways, including critical variants like GLP1R rs6923761 and FTO rs9939609 that predict your medication responsiveness. This testing allows your clinician to anticipate whether you'll benefit from staying at 1.0 mg or potentially progressing to 2.4 mg for optimal outcomes.
Personalized dosing also accounts for your lifestyle, concurrent medications, and gastrointestinal sensitivity. A patient with a history of IBS may benefit from a slower titration or a slightly lower maintenance dose, while someone with aggressive metabolic dysfunction might progress more quickly. PlexusDx compounds your medication through licensed 503A pharmacies, enabling dose adjustments that align with your clinical response rather than forcing you into preset commercial vial sizes. This flexibility means your treatment adapts to you, not the reverse.
Managing Side Effects During Dose Escalation
Nausea and constipation are the most common side effects during semaglutide titration, but both typically decrease as your body adjusts. Most nausea occurs in the first 24-48 hours after injection and resolves by mid-week, allowing you to function normally most days. If side effects become limiting at a particular dose, your PlexusDx clinician can extend your time at that level before advancing, or recommend dietary modifications that ease gastrointestinal symptoms. Staying hydrated, eating smaller meals, and consuming high-fiber foods early in treatment often reduce discomfort significantly.
Severe or persistent side effects warrant an honest conversation with your provider about whether a lower maintenance dose might achieve your goals while improving quality of life. Some patients find optimal results at 1.0 mg or 1.7 mg rather than pursuing the highest possible dose. Your clinical team's role is balancing efficacy with tolerability—not pushing you toward a dose that causes suffering. PlexusDx telehealth clinicians monitor your response regularly and adjust recommendations based on your real-world experience, not theoretical protocols.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What dose of semaglutide should I start on?
PlexusDx begins all new patients on 0.25 mg weekly during week one, regardless of your target weight loss. This introductory dose allows your GLP-1 receptors to activate gradually while minimizing nausea. Your clinician will progress your dose based on tolerability and response, with most patients advancing 0.25 mg every month until reaching their target.
How long does semaglutide titration typically take?
Standard titration from 0.25 mg to a therapeutic dose of 1.0-2.4 mg takes 16-20 weeks when advancing monthly. Some patients progress faster or slower depending on side effect tolerance and clinical response. PlexusDx personalizes your timeline—your dose may need to go up, your price won't.
Does PlexusDx adjust my dose without increasing my monthly cost?
Yes. PlexusDx compounded semaglutide injections start at $149 per month, and this flat rate applies whether your dose is 0.25 mg or 2.4 mg. You never pay more as your dose increases—pricing stays constant across all titration phases and maintenance levels.
Can I stay on a lower dose if I'm seeing good results?
Absolutely. If you reach meaningful weight loss and appetite control at 1.0 mg or 1.7 mg, continuing that dose is medically appropriate. Your clinician won't push you to higher doses unnecessarily. The goal is sustainable weight management at a dose you tolerate well, not maximal dosing for its own sake.
How does the PlexusDx genetic test help with dosing decisions?
The Precision Peptide Genetic Test ($99 after your first month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence your medication response. These insights help your clinician predict whether you'll need a higher final dose or achieve results at a standard level, allowing truly personalized dosing from the start.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Mastering Your Journey: What’s the Best Way to Take Ozempic® for Effective Weight Management?
Does Wegovy Help with A1C? What You Need to Know About Blood Sugar and Weight Loss